Liraglutide for weight loss in obese people.
Thomas
T
Thum
Stefan D
SD
Anker
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D015897:Comorbidity; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D000069450:Liraglutide; D008297:Male; D024821:Metabolic Syndrome; D009765:Obesity / Q000188:drug therapy*; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects*
D019440:Anti-Obesity Agents; D054795:Incretins; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1